Bluefin Capital Management’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

Bluefin Capital Management’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-59,300	Closed	-$400K	–	629
2013 Q2	$400K	Buy	+59,300	New	+$355K	0.04%	364

Other funds holding PBTH

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Bluefin Capital Management's PBTH Position: Q3 2013 in Review

Bluefin Capital Management sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 59,300 shares — an estimated $400K sold.

Bluefin Capital Management first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $400K in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

Bluefin Capital Management reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
Bluefin Capital Management sold 59,300 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $400K.
Bluefin Capital Management first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
Bluefin Capital Management's PROLOR Biotech, Inc. Common Stock position peaked at $400K in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on Bluefin Capital Management's 13F filing for Q3 2013, filed 12 Nov 2013.